Sun Pharma gets relief in trademark case from High Court

The Bombay High Court has ruled in favour of Sun Pharmaceutical Industries. The court has restrained United Biotech from using a similar trademark. Sun Pharma's 'Octride' mark is protected. The dispute involves drugs for acromegaly and carcinoid tumours. The court found Sun Pharma had a stronger claim. This decision protects Sun Pharma's reputation and goodwill.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bCipSD7
via IFTTT